Pharma News

Stakeholder Capitalism: Q&A with Meg Alexander, Chief Strategy Officer at Ovid Therapeutics (Part 2)

Alexander continues her conversation, touching on topics like disinformation and diversity in clinical trials.

Source link
#Stakeholder #Capitalism #QampA #Meg #Alexander #Chief #Strategy #Officer #Ovid #Therapeutics #Part

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *